Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.118
Sell
RSI(14)
49.797
Neutral
STOCH(KDJ)(9,3,3)
28.264
Buy
ATR(14)
0.491
High Vlolatility
CCI(14)
-49.367
Neutral
Williams %R
58.644
Sell
TRIX(12,20)
-0.015
Sell
StochRSI(14)
92.205
Buy
Medifast Inc
MED11.360USD
+0.530+4.89%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
124.86MMarket Cap
496.50P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Medifast Inc
Currency: USD Updated: 2026-02-06Key Insights
Medifast Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 47 out of 96 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 15.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Medifast Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Medifast Inc Highlights
StrengthsRisks
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Overvalued
The company’s latest PE is 496.50, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 9.30M shares, decreasing 27.43% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 711.50K shares of this stock.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
15.000
Target Price
+38.50%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-06The current financial score of Medifast Inc is 6.87, ranking 56 out of 96 in the Food & Tobacco industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 89.41M, representing a year-over-year decrease of 36.21%, while its net profit experienced a year-over-year decrease of 300.27%.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.43
Operational Efficiency
8.04
Growth Potential
4.82
Shareholder Returns
9.06
Medifast Inc's Company Valuation
Currency: USD Updated: 2026-02-06The current valuation score of Medifast Inc is 8.68, ranking 13 out of 96 in the Food & Tobacco industry. Its current P/E ratio is 496.50, which is 8.80% below the recent high of 540.21 and 104.45% above the recent low of -22.09.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 47/96
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of Medifast Inc is 6.00, ranking 57 out of 96 in the Food & Tobacco industry. The average price target is 15.00, with a high of 15.00 and a low of 15.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
15.000
Target Price
+38.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
57
Total
7
Median
8
Average
Company name
Ratings
Analysts
Medifast Inc
MED
2
Mondelez International Inc
MDLZ
28
Hershey Co
HSY
25
Kraft Heinz Co
KHC
22
International Flavors & Fragrances Inc
IFF
21
General Mills Inc
GIS
21
1
2
3
...
12
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-06The current price momentum score of Medifast Inc is 5.07, ranking 85 out of 96 in the Food & Tobacco industry. Currently, the stock price is trading between the resistance level at 12.06 and the support level at 10.73, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
11.168
Buy
MA10
11.308
Buy
MA20
11.527
Sell
MA50
11.338
Buy
MA100
12.047
Sell
MA200
12.839
Sell
Institutional Confidence
Currency: USD Updated: 2026-02-06The current institutional shareholding score of Medifast Inc is 7.00, ranking 23 out of 96 in the Food & Tobacco industry. The latest institutional shareholding proportion is 84.58%, representing a quarter-over-quarter increase of 5.59%. The largest institutional shareholder is James Simons, holding a total of 800.91K shares, representing 7.29% of shares outstanding, with 9.90% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Charles Schwab Investment Management, Inc.
BofA Global Research (US)
Two Sigma Investments, LP
Acadian Asset Management LLC
Parametric Portfolio Associates LLC
Lido Advisors, LLC
AQR Capital Management, LLC
1
2
Risk Assessment
Currency: USD Updated: 2026-02-06The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Tobacco domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Medifast Inc is 5.66, ranking 49 out of 96 in the Food & Tobacco industry. The company's beta value is 0.54. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.54
VaR
+4.66%
240-Day Maximum Drawdown
+31.67%
240-Day Volatility
+42.82%
Return
Best Daily Return
60 days
+5.29%
120 days
+5.75%
5 years
+12.12%
Worst Daily Return
60 days
-4.53%
120 days
-5.42%
5 years
-22.47%
Sharpe Ratio
60 days
-0.34
120 days
-0.66
5 years
-1.10
Risk Assessment
Maximum Drawdown
240 days
+31.67%
3 years
+90.29%
5 years
+96.87%
Return-to-Drawdown Ratio
240 days
-0.73
3 years
-0.33
5 years
-0.20
Skewness
240 days
+0.11
3 years
-0.95
5 years
-0.61
Volatility
Realised Volatility
240 days
+42.82%
5 years
+49.23%
Standardised True Range
240 days
+4.50%
5 years
+34.14%
Downside Risk-Adjusted Return
120 days
-111.96%
240 days
-111.96%
Maximum Daily Upside Volatility
60 days
+25.46%
Maximum Daily Downside Volatility
60 days
+23.47%
Liquidity
Average Turnover Rate
60 days
+2.08%
120 days
+2.06%
5 years
--
Turnover Deviation
20 days
-33.15%
60 days
-23.28%
120 days
-24.15%
Peer Comparison
Food & Tobacco
Medifast Inc
MED
6.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Andersons Inc
ANDE
8.83 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Post Holdings Inc
POST
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Darling Ingredients Inc
DAR
8.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
International Flavors & Fragrances Inc
IFF
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bunge Global SA
BG
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
